AMENDMENT NO. 1 TO LICENSING AGREEMENT BETWEEN TULARIK INC. AND ELI LILLY AND COMPANYLicensing Agreement • August 13th, 2001 • Tularik Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (this "Amendment") to the Licensing Agreement dated as of September 30, 1999 (the "Agreement") by and between Eli Lilly And Company, an Indiana corporation, having offices at Lilly Corporate Center, Indianapolis, Indiana 46285 ("Lilly"), and Tularik Inc., a Delaware corporation having offices at Two Corporate Drive, South San Francisco, California 94080 ("Tularik"), is entered into as of January 10, 2001. Lilly and Tularik may be referred to herein individually as a "Party" or, collectively, as "Parties".
AMENDMENT NO. 1 TO COLLABORATION AGREEMENT BETWEEN TULARIK INC. AND JAPAN TOBACCO INC.Collaboration Agreement • August 13th, 2001 • Tularik Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (this "Amendment") to the Collaboration Agreement dated as of June 1, 2000 (the "Agreement") by and between Japan Tobacco, a Japanese corporation, having offices at JT Building, 2-1 Toranomon, 2-chome, Minato-ku, Tokyo 105, Japan ("JT"), and Tularik Inc., a Delaware corporation having offices at Two Corporate Drive, South San Francisco, California 94080 ("Tularik"), is entered into as of January 1, 2001. JT and Tularik may be referred to herein as a "Party" or, collectively, as "Parties".
AMENDMENT NO. 2 TO COLLABORATION AGREEMENT BETWEEN TULARIK INC. AND JAPAN TOBACCO INC.Collaboration Agreement • August 13th, 2001 • Tularik Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 2 (this "Amendment") to the Collaboration Agreement dated as of June 1, 2000 (the "Agreement") by and between Japan Tobacco Inc., a Japanese corporation, having offices at JT Building, 2-1 Toranomon, 2-chome, Minato-ku, Tokyo 105, Japan ("JT"), and Tularik Inc., a Delaware corporation having offices at Two Corporate Drive, South San Francisco, California 94080 ("Tularik"), is entered into as of May 31, 2001. JT and Tularik may be referred to herein as a "Party" or, collectively, as "Parties".
AMENDMENT NO. 1 TO COLLABORATION AGREEMENT BETWEEN TULARIK INC. AND KNOLL AGCollaboration Agreement • August 13th, 2001 • Tularik Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (this "Amendment") to the Collaboration Agreement dated as of November 1, 1998 (the "Agreement") by and between Knoll AG, a German corporation, having offices at Knollstrasse, 67061 Ludwigshafen, Germany ("Knoll"), and Tularik Inc., a Delaware corporation having offices at Two Corporate Drive, South San Francisco, California 94080 ("Tularik"), is entered into as of August 15, 2000. Knoll and Tularik may be referred to herein as a "Party" or, collectively, as "Parties".
AMENDMENT NO. 2 TO RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN TULARIK INC. AND SYNTEX (U.S.A.) LLCResearch Collaboration and License Agreement • August 13th, 2001 • Tularik Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 2 (this "Amendment") to the Research Collaboration and License Agreement dated as of July 8, 1997 (the "Agreement") by and between Syntex (U.S.A.) Inc., a Delaware corporation that has been merged into Syntex (U.S.A.) LLC, through its Roche Bioscience division, having offices at 3401 Hillview Avenue, Palo Alto, California 94304 ("Roche Bioscience"), and Tularik Inc., a Delaware corporation having offices at Two Corporate Drive, South San Francisco, California 94080 ("Tularik"), is entered into as of August 31, 2000. Roche Bioscience and Tularik may be referred to herein as a "Party" or, collectively, as "Parties."
